The Latest

RegenMed is pleased to announce that Mr. Dolph Courchaine has joined the company as Chief Information Technology Officer. Dolph brings to the company 30 years of senior level IT experience with large hospital systems and health plan insurers. Dolph started his career as a software engineer for a Staff Model HMO and quickly progressed into leadership roles across many Health System owned Health Plans. He oversaw the IT division of a University owned managed care organization, subsequently sold to BlueCross/BlueShield of Michigan. He was the functional health plan CIO for a $3.5 billion integrated healthcare system. Dolph served as the CIO of WellMed Medical Management, a $1 billion dollar privately owned healthcare delivery and financial risk-bearing entity that was subsequently acquired by Optum. Dolph was responsible for all IT supporting the $3 billion group of the Geisinger health plans. Most recently, Dolph has served as a strategic consultant to regional based health systems that own health plans as well as with OptumCare, a major subsidiary of the United Health Group. He has a broad and deep set of experience in application engineering, technology management, health care insurance, and health care delivery As real world evidence and data licensing become more important to all hospitals and health insurance plans, Dolph’s expertise will be invaluable in helping RegenMed expand its patented technical platforms into enterprise wide deployments.

Physicians-Owned Circles in the large and dynamic physical therapy market are examples of RegenMed’s accelerating market traction. In the U.S. alone, this market is valued at about $50 bn, and is expected to grow by at least 18% over the next decade. The demand for physical therapy is fueled by a rise in chronic diseases, an expanding aging population, increased healthcare spending, and an increase demand for rehabilitation therapists to meet the needs of these populations. Also, private insurers and government health programs are increasingly turning to low-cost/high-quality outpatient providers such as physical therapists. Innovations in orthopedic treatments practices are also leading to post-surgery PT services. As one illustration, Paul Hobrough is the Principal Investigator for a Physicians-Owned Circle covering the use of hydrogels – itself a $47 billion market – in the context of shockwave therapies. Paul, based in the United Kingdom, is an internationally recognized speaker and teacher in the field. Through his broad network of additional investigators, the POC will rapidly generate multiple licensable real-world datasets advancing the field, while financially benefiting all POC members. There are an estimated 320,000 licensed physical therapists in the U.S., with an even larger number on a per capita basis in many European countries. Each of these is a potential member of one or more PT-related Physicians-Owned Circles. As such, they will generate validated and clinically significant real world datasets of high value to product manufacturers, employers, payers, and other healthcare constituencies. This is the clinical and financial power of Physicians-Owned Circles.

The healthcare data analytics market is worth $64 billion, with a forecasted 21% annual growth 1. At the same time, there is a strong focus on the importance of real-world data. Through its patented Circles platform, RegenMed is well positioned to exploit both of these powerful trends on an enterprise level. Everyday physician-patient interactions — correlated to long-term outcomes — are the largest and best source of real world data. In the US alone, over 1 billion such interactions take place each year at 7,400 hospitals, 9,600 ambulatory surgery centers and 340,000 physician group practices 2. Larger hospital systems are now monetizing their traditional electronic medical record data. However, they are investing heavily to do so. Moreover, the ownership, clinical significance, and reliability of EMR datasets are open to question. In contrast, Circles represent a clinical grade, low cost and highly efficient method to develop and monetize real-world datasets. Circles datasets are generated through a patented and minimally burdensome closed system. This enable the generation of healthcare datasets which are regularly updated, clinically significant, “hallucination” free, and protected from third-party claims of ownership.Hospitals and other provider groups are facing strong financial headwinds. Reimbursement rates are declining while costs are increasing. EMR and other IT costs are failing to deliver the promised patient care or economic returns. Circles generate a new and accumulating revenue source at a small fraction of typical IT expenditures. Moreover, Circles datasets lead to genuine value-based care, health equity, and deeper engagement with physicians and patients. For RegenMed, proprietary and monetizable Circles datasets are the foundation of accelerating enterprise sales.

Our December 16, 2024 Investors Webinar – Expectations 2025 – was well attended and well received. We thank and welcome all of our new investors, including our first fund. During the webinar, Michael Tierney, the Company’s co-founder and CEO, covered the planned 2025 acceleration of its 2024 market traction. As he explained, the demand for Circles real-world evidence datasets is likely to expand significantly in the coming years As a “Zero-To-One” company with growing recurring revenues, RegenMed is focused on rapid scaling within its large markets. While not specifying current Company valuations, Mr. Tierney discussed the rapid growth in recurring revenues and corresponding market value of several other SaaS companies. Mr. Tierney also identified strategic exits of relevant healthcare data companies at large valuations. These included CorEvitas, acquired by Thermo Fisher for $913 million in cash in 2023. Like RegenMed, CorEvitas focuses on real-world evidence. Mr. Tierney reviewed as an example of the Company’s progress the enthusiastic adoption of Physicians-Owned Circles commencing in the fourth quarter of 2024. The Company is preparing a series of YouTube videos covering major topics presented during the December 16 webinar. Once published, these will also be available on the Company’s Investors Page, with links also provided in future StartEngine campaign page updates.

The fast-growing shockwave market is already valued at $3 billion. Manufacturers around the world are investing in new devices and applicators to address the rising demand for non-surgical therapeutic options. They need clinical evidence to support those new technologies. Increasingly, that evidence will not come from clinical trials, but your everyday clinical data and outcomes.Physicians-Owned Circles (POCs) streamline the capture, aggregation and licensure of high-quality, real-world shockwave data. Qualifying Principal Investigators receive 10% of resulting license fees, and qualifying Investigators share 75%. Cost and time obligations are minimal, and the data is yours to use for various non-commercial purposes.